{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:38:06Z","timestamp":1712968686567},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,12]]},"DOI":"10.7759\/cureus.58140","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T20:52:17Z","timestamp":1712955137000},"source":"Crossref","is-referenced-by-count":0,"title":["First Case of FLT3-Tyrosine Kinase Domain Mutant Acute Myeloid Leukemia With Unusual Onset as Isolated Bilateral Testicular Myeloid Sarcoma"],"prefix":"10.7759","author":[{"given":"Veysel","family":"Erol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsum","family":"Akgun Cagliyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furkan","family":"Ufuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman JW","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002, 100:2292-302. 10.1182\/blood-2002-04-1199","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1999.00651.x","article-title":"Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases","volume":"34","author":"Menasce LP","year":"1999","unstructured":"Menasce LP, Banerjee SS, Beckett E, Harris M. Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology. 1999, 34:391-8. 10.1046\/j.1365-2559.1999.00651.x","journal-title":"Histopathology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst RL","year":"2011","unstructured":"Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011, 118:3785-93. 10.1182\/blood-2011-04-347229","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347872","article-title":"Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007","volume":"119","author":"Dores GM","year":"2012","unstructured":"Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012, 119:34-43. 10.1182\/blood-2011-04-347872","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10399","article-title":"Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature","volume":"94","author":"Yamauchi K","year":"2002","unstructured":"Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002, 94:1739-46. 10.1002\/cncr.10399","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810915)48:6<1426::aid-cncr2820480626>3.0.co;2-g","article-title":"Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases","volume":"48","author":"Neiman RS","year":"1981","unstructured":"Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE, Bennett JM. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981, 48:1426-37. 10.1002\/1097-0142(19810915)48:6&lt;1426::aid-cncr2820480626&gt;3.0.co;2-g","journal-title":"Cancer"},{"key":"ref7","article-title":"Extramedullary myeloid cell tumors arising in the setting of chronic myelomonocytic leukemia. A report of two cases","volume":"120","author":"Elenitoba-Johnson K","year":"1996","unstructured":"Elenitoba-Johnson K, Hodges GF, King TC, Wu CD, Medeiros LJ. Extramedullary myeloid cell tumors arising in the setting of chronic myelomonocytic leukemia. A report of two cases. Arch Pathol Lab Med. 1996, 120:62-7.","journal-title":"Arch Pathol Lab Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-091215","article-title":"Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients","volume":"111","author":"Bacher U","year":"2008","unstructured":"Bacher U, Haferlach C, Kern W, Haferlach T, Schnittger S. Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients. Blood. 2008, 111:2527-37. 10.1182\/blood-2007-05-091215","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209999","article-title":"Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome","volume":"114","author":"Kayser S","year":"2009","unstructured":"Kayser S, Schlenk RF, Londono MC, et al.. Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome. Blood. 2009, 114:2386-92. 10.1182\/blood-2009-03-209999","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil E","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, et al.. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016, 374:2209-21. 10.1056\/NEJMoa1516192","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede C","year":"2002","unstructured":"Thiede C, Steudel C, Mohr B, et al.. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood. 2002, 99:4326-35. 10.1182\/blood.v99.12.4326","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.186","article-title":"The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia","volume":"27","author":"Allen C","year":"2013","unstructured":"Allen C, Hills RK, Lamb K, et al.. The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia. Leukemia. 2013, 27:1891-901. 10.1038\/leu.2013.186","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.04.013","article-title":"Testicular myeloid sarcoma: a systematic review of the literature","volume":"19","author":"Sahu KK","year":"2019","unstructured":"Sahu KK, Sherif AA, Mishra AK, Lal A, Singh A. Testicular myeloid sarcoma: a systematic review of the literature. Clin Lymphoma Myeloma Leuk. 2019, 19:603-18. 10.1016\/j.clml.2019.04.013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.79","article-title":"Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set","volume":"7","author":"Goyal G","year":"2017","unstructured":"Goyal G, Bartley AC, Patnaik MM, Litzow MR, Al-Kali A, Go RS. Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set. Blood Cancer J. 2017, 7:e592. 10.1038\/bcj.2017.79","journal-title":"Blood Cancer J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63052-0","article-title":"Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement","volume":"159","author":"Park KU","year":"2001","unstructured":"Park KU, Lee DS, Lee HS, Kim CJ, Cho HI. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement. Am J Pathol. 2001, 159:2011-6. 10.1016\/S0002-9440(10)63052-0","journal-title":"Am J Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200310000-00004","article-title":"Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group","volume":"25","author":"Dusenbery KE","year":"2003","unstructured":"Dusenbery KE, Howells WB, Arthur DC, et al.. Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol. 2003, 25:760-8. 10.1097\/00043426-200310000-00004","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1309\/NXLCJ1B16YDFQWND","article-title":"Myeloid sarcoma involving the testis","volume":"124","author":"Valbuena JR","year":"2005","unstructured":"Valbuena JR, Admirand JH, Lin P, Medeiros LJ. Myeloid sarcoma involving the testis. Am J Clin Pathol. 2005, 124:445-52. 10.1309\/NXLCJ1B16YDFQWND","journal-title":"Am J Clin Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0116","article-title":"Acute myeloid leukemia, version 3.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"O'Donnell MR","year":"2017","unstructured":"O'Donnell MR, Tallman MS, Abboud CN, et al.. Acute myeloid leukemia, version 3.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017, 15:926-57. 10.6004\/jnccn.2017.0116","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/237707-first-case-of-flt3-tyrosine-kinase-domain-mutant-acute-myeloid-leukemia-with-unusual-onset-as-isolated-bilateral-testicular-myeloid-sarcoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T20:52:22Z","timestamp":1712955142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/237707-first-case-of-flt3-tyrosine-kinase-domain-mutant-acute-myeloid-leukemia-with-unusual-onset-as-isolated-bilateral-testicular-myeloid-sarcoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.58140","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,12]]}}}